 |
|
|
|
Men's Health | Women's Health | Children's Health | Elder Health Holistic Health | Healthy Heart | Cancer | Weight Loss Exercise & Fitness | Healthy Resources | HOME PAGE Health Club 101 DIRECT Natural Supplements | HGH Energizer | Eazol Natural Pain Relief | Revitol Cellulite Solution IBS Irritable Bowel Syndrome | Menopause Symptoms Relief | Insomnia Sleeping Aid Articles & Information Medicine | Nutrition | Exercise | Fitness Equipment | Pregnancy Bodybuilding Supplements | Weight Loss | Breast Cancer | Diabetes Category Site Map |
 |
Orphan Drugs: Hope Where There Is Little or No Hope
NEW YORK, N.Y., February 18, 2004 - On a visit to his doctor, Gary Jacob received distressing news - not about himself, but a friend of the doctor's. While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis - he had a disease known as multiple myeloma, a bone marrow blood cancer. The diagnosis was nothing less than a death sentence. Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive. Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients. "The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients." In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline. Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process. The program covers drugs for orphan diseases with patient populations under 200,000. The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases. Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases. Large drug-makers have been largely missing from the efforts. According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies. The reason: expectations of unfavorable investment returns. The FDA orphan drug incentives - grants, seven years of marketing exclusivity and tax breaks - have drawn small pharmaceutical companies with promising drug candidates into the breach. While the future is brighter, the task is still daunting to develop drugs for orphan diseases. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients. Some diseases affect fewer than 100 patients, according to the National Institutes of Health. An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available. Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma. "He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. " Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School. The Phase I/IIa trials for Atiprimod are slated to begin later this month. Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising. "In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways - by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker. About The Author Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets.
MORE RESOURCES:
Men's Health
|
Women's
Health |
Children's
Health |
Elder
Health
Medicine - Google News |
|
|
|
RELATED ARTICLES
Catch The Wave There has never been a better opportunity for chiropractic medicine?and it's going to get even better!Living in Southern California the ocean waves and the surfing environment inspire you. You cannot help but draw the analogy of "catching the wave" during the most exciting time I have experienced in chiropractic medicine over the past 15 years. Can Mexican Pharmacy Purchases Be Trusted? Purchasing drugs from a Mexican pharmacy is, for the most part, a very safe and inexpensive way of getting the medical supplies that you require. Since the laws in Mexico are very different than in the US, as most drugs are readily available without a prescription (except for some controlled substances and all narcotics), purchasing drugs from a Mexican pharmacy should be a fairly painless process. Vioxx and Bextra Lawsuits Could Tie Up Courts for Years In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling medication Vioxx from the market. Studies show that Vioxx increases the risk of heart attack and stroke among patients who have used the drug for longer than 18 months. Cold-Eeze Side Effects Lawyer: Zinc Destroys Sense of Smell! Cold-Eeze is a homeopathic solution to the common cold. It is a zinc-based solution that can be taken as a tablet or a nasal spray. Bextra Withdrawal Could Be Just the Beginning for Pfizer The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Resperate or RESPeRATE - this device controls blood pressure however you spell it! Resperate is natural and powerful and it puts you in control of your blood pressure.Resperate is a new device and is revolutionising the nature of blood pressure treatment. Lunesta Tolerance Lunesta is a newly released sleeping pill. Marketed as a revolutionary sleep aid, Lunesta is the only medication approved by the FDA for long term treatment of insomnia symptoms. Zyprexa - History of the Drug Since the beginning of mankind, mental illness has played a role in our society. Victims of such illnesses have been outcast, stereotyped and often ridiculed. 7 Tips to Keep Your Fluid Down on Dialysis As any dialysis patient will tell you, keeping your fluid gain between dialysis sessions in check is not only important to your long term health, it is a major factor in your immediate well-being.Keeping fluid level gains as low as possible between dialysis treatments will minimize the risk of congestive heart failure, pulmonary oedema, and hypertension. Interactive Technology in Healthcare Education Healthcare professionals are under pressure to remember, utilize and absorb vast amounts of new or changing information in increasing volume. This surge has led to new and improved computer-based tools for many healthcare activities and to an explosion in the marketplace of tools used in instruction and education of healthcare workers. Why Drug Companies are Naughty and 5 Remedies to Cure the Symptoms With the hum of the election campaign and the debate of "big business," versus human interest, I decided to do a bit of muckraking into the art and science of the recent removal of Merck's Vioxx. My motivation of course; to look for clues as to the role drug companies play in our health and wellness (or lack thereof). Signs of an Addiction Addictions come in many forms. It's important to recognize the signs of addictions in order to seek out help before the problem becomes to large. New Company Helps Another Medical Condition Become: "Acceptable" Dinner Conversation Recently once taboo subjects like plastic surgery have become acceptable dinner conversation. Medical conditions are no longer whispered to friends, but have instead become part of the dinner table conversation with full blown discussions on Botox, erectile dysfunction and the feared colonoscopy. Powerful Arthritis Pain Relief For All Of Us When you ask what arthritis is, professinals will tell you it's inflammation of one or more joints. But you know it better as pain, swelling, stiffness, deformity, and/or a diminished range of motion of those joints! It's estimated that over 50 million Americans suffer from osteoarthritis, rheumatoid arthritis and other related conditions. What You Should Know About Mixing Medications and Diet... I had a call the other day from a potential client in a serious situation. He was young and had been diagnosed with CAD (Coronary Artery Disease), suffering from extremely high blood pressure and cholesterol, his doctor had put him on a medication that was suppose to lower and control these symptoms, and he had been on this medication for over 2 years. Robotic Future of Hospitals; Pandemic Prevention and Bio-Terrorist Attack There is a huge concern in the medical industry that if a biological weapon were released that those sick might come to the hospitals in such large numbers that before you realized an attack had occurred everyone in every nearby hospital would also be infected. Then of course the hospital itself would be rendered useless and all those already in the hospital no matter what the reason would literally condemned. Alprazolam/Xanax - A Habit Forming Drug Xanax is a Prescription Drug which is habit forming. You can become physically and psychologically dependent on the Xanax medication. Dangerous Drugs Vioxx, Celebrex, and Bextra: An editorial regarding dangerous drugsGenerally my web site deals with Internet and other media markets, but whereas our motto is "Caveat Emptor, Let the buyer beware " and is consumer advocacy oriented, we will from time to time discuss anything in that is relevent to warning readers of problems.This is one of those instances where the public should be aware of what's going on. Hypnotherapy as a Treatment for IBS Hypnotherapy is one of the best known and most widely used treatments for IBS, and can offer sufferers a drug-free solution to their symptoms of diarrhea, constipation, stomach pain and bloating.There are now many hundreds of hypnotherapists who offer what is called "gut-directed hypnotherapy" for IBS, which takes the general techniques of hypnotherapy and applies them directly to the abdominal pain and digestive symptoms which IBS sufferers struggle with. The Importance Of Using Electric Wheelchairs To Improve Mobility No person likes to feel housebound and dependent on others. While people who have been injured or suffering from a debilitating disease may not have full functionality of their motor skills, it is still possible for them to be semi-independent and mobile.
|
|
home | site map Men's Health | Women's Health | Children's Health | Elder Health Holistic Health | Healthy Heart | Cancer | Weight Loss Exercise & Fitness | Healthy Resources |
|
|
